Atria Wealth Solutions Inc. Grows Position in Humana Inc. (NYSE:HUM)

Atria Wealth Solutions Inc. grew its holdings in Humana Inc. (NYSE:HUM) by 21.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,610 shares of the insurance provider’s stock after buying an additional 281 shares during the period. Atria Wealth Solutions Inc.’s holdings in Humana were worth $409,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the stock. AMF Tjanstepension AB raised its stake in shares of Humana by 166.8% in the third quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock valued at $12,686,000 after acquiring an additional 25,041 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Humana by 12.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,090 shares of the insurance provider’s stock worth $1,295,000 after purchasing an additional 461 shares during the period. AustralianSuper Pty Ltd grew its holdings in Humana by 35.2% during the 3rd quarter. AustralianSuper Pty Ltd now owns 2,495 shares of the insurance provider’s stock valued at $790,000 after purchasing an additional 650 shares during the last quarter. Creative Financial Designs Inc. ADV raised its position in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the period. Finally, CacheTech Inc. lifted its stake in Humana by 5.7% in the third quarter. CacheTech Inc. now owns 7,818 shares of the insurance provider’s stock worth $2,476,000 after purchasing an additional 422 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on HUM shares. Wells Fargo & Company cut their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a report on Tuesday. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Finally, JPMorgan Chase & Co. reduced their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Nineteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $285.68.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.32% of the stock is owned by corporate insiders.

Humana Trading Up 2.5 %

NYSE:HUM opened at $261.49 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a fifty day simple moving average of $270.64 and a 200-day simple moving average of $287.87. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a market capitalization of $31.55 billion, a P/E ratio of 26.28, a PEG ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.